ESR1 and breast carcinoma: It is reported that KDM5C activates estrogen receptor alpha (ERα) target genes while inhibiting type I interferon (IFN) and interferon stimulating genes to promote the growth of ERα-positive breast cancer cells and tumorigenesis [22].